Specialties
Classics™
COVID Central
Rewinds
- Click for the Rewinds Archive
Write for Us
- Writer Application
- Submit an Opinion
Subscribe
For Partners
Account

Search

Monday, May 10, 2021

About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us

2 Minute Medicine

Specialties
- All Cardiology Chronic Disease Dermatology Emergency Endocrinology Gastroenterology Hematology Imaging and Intervention Infectious Disease Nephrology Neurology Obstetrics Oncology Ophthalmology Orthopedic Surgery Pediatrics Preclinical Psychiatry Public Health Pulmonology Rheumatology Surgery Urology
  
  Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis
  
  Upadacitinib non-inferior to adalimumab for psoriatic arthritis treatment
  
  Lumasiran decreases urinary oxalate excretion in Primary Hyperoxaluria Type 1
  
  Special Report: Psychedelics in Medicine Part 1: Psychedelics as a potential…
Classics™
COVID Central
Rewinds
- Special Rewind: Psychedelics Edition. May 10, 2021
  
  2 Minute Medicine Rewind May 3, 2021
  
  2 Minute Medicine Rewind April 26, 2021
  
  2 Minute Medicine Rewind April 19, 2021
  
  2 Minute Medicine Rewind April 12, 2021
- Click for the Rewinds Archive
Write for Us
- Writer Application
- Submit an Opinion
Subscribe
For Partners
Account

Podcasts

2 Minute Medicine Physician Press Podcast – December 2017

December 31, 2017 | 2MM

Previous articleReduced mortality with culprit-lesion-only percutaneous coronary intervention for acute myocardial infarction with cardiogenic shock

Next articleProphylactic letermovir significantly reduces cytomegalovirus infection after transplantation

2MM

2 Minute Medicine Physician Press Podcast January 2018

2 Minute Medicine Physician Press Podcast – August 2016

2 Minute Medicine Physician Press Podcast – December 2015

Most Recent

Rifapentine-moxifloxacin noninferior to standard of care treatment for pulmonary tuberculosis
Upadacitinib non-inferior to adalimumab for psoriatic arthritis treatment
Lumasiran decreases urinary oxalate excretion in Primary Hyperoxaluria Type 1
Special Report: Psychedelics in Medicine Part 1: Psychedelics as a potential therapeutic option for psychiatric conditions
Special Rewind: Psychedelics Edition. May 10, 2021

All-time hits

The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics...

July 16, 2013

Classics Series, Landmark Trials in Medicine

The CLOT trial: Dalteparin versus warfarin [Classics Series]

December 7, 2014

Updated JNC 8 guidelines for antihypertensive drugs released

December 19, 2013

ABOUT US

2 Minute Medicine® is an award winning, physician-run, expert medical media company originally founded out of Harvard Medical School and the Massachusetts Institute of Technology. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Contact us: info@2minutemedicine.com

License Content
Terms of Use | Disclaimer
Log-In
Edit Account
Register
Log out
Manage Subscription
Cookie policy
Privacy statement (EU)
Disclaimer